Literature DB >> 25837747

In reply.

Stefan Feiten, Jan Dünnebacke, Rudolf Weide.   

Abstract

Mesh:

Year:  2015        PMID: 25837747      PMCID: PMC4383857          DOI: 10.3238/arztebl.2015.0176

Source DB:  PubMed          Journal:  Dtsch Arztebl Int        ISSN: 1866-0452            Impact factor:   5.594


× No keyword cloud information.
  5 in total

1.  Functional limitations in elderly female cancer survivors.

Authors:  Carol Sweeney; Kathryn H Schmitz; DeAnn Lazovich; Beth A Virnig; Robert B Wallace; Aaron R Folsom
Journal:  J Natl Cancer Inst       Date:  2006-04-19       Impact factor: 13.506

2.  The risk of developing arm lymphedema among breast cancer survivors: a meta-analysis of treatment factors.

Authors:  Rebecca J Tsai; Leslie K Dennis; Charles F Lynch; Linda G Snetselaar; Gideon K D Zamba; Carol Scott-Conner
Journal:  Ann Surg Oncol       Date:  2009-04-14       Impact factor: 5.344

3.  Patient-reported outcomes in sentinel node-negative adjuvant breast cancer patients receiving sentinel-node biopsy or axillary dissection: National Surgical Adjuvant Breast and Bowel Project phase III protocol B-32.

Authors:  Stephanie R Land; Jacek A Kopec; Thomas B Julian; Ann M Brown; Stewart J Anderson; David N Krag; Nicholas J Christian; Joseph P Costantino; Norman Wolmark; Patricia A Ganz
Journal:  J Clin Oncol       Date:  2010-08-02       Impact factor: 44.544

4.  Breast cancer morbidity: questionnaire survey of patients on the long term effects of disease and adjuvant therapy.

Authors:  Stefan Feiten; Jan Dünnebacke; Jochen Heymanns; Hubert Köppler; Jörg Thomalla; Christoph van Roye; Diana Wey; Rudolf Weide
Journal:  Dtsch Arztebl Int       Date:  2014-08-04       Impact factor: 5.594

5.  Quality of life following breast-conserving therapy or mastectomy: results of a 5-year prospective study.

Authors:  Jutta Engel; Jacqueline Kerr; Anne Schlesinger-Raab; Hansjörg Sauer; Dieter Hölzel
Journal:  Breast J       Date:  2004 May-Jun       Impact factor: 2.431

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.